NLRP3 and hypertensive disorder: Taken together, although diuretics are in many cases successfully given to people to treat high blood pressure, their ability to inhibit the WNK1 signaling pathway at the level of the Na+/K+/Cl− co-transporters and their effect on blood K+ levels may increase the severity of NLRP3-related inflammatory complications such as gout.